Yung-Feng Liao

652 total citations
20 papers, 504 citations indexed

About

Yung-Feng Liao is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Yung-Feng Liao has authored 20 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Neurology and 8 papers in Physiology. Recurrent topics in Yung-Feng Liao's work include Neuroblastoma Research and Treatments (9 papers), Alzheimer's disease research and treatments (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Yung-Feng Liao is often cited by papers focused on Neuroblastoma Research and Treatments (9 papers), Alzheimer's disease research and treatments (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Yung-Feng Liao collaborates with scholars based in Taiwan, United States and Japan. Yung-Feng Liao's co-authors include Wen‐Ming Hsu, Hsinyu Lee, Pei‐Yi Wu, Hsueh‐Fen Juan, Chang-Jen Huang, Kai‐Hsin Lin, Hsiu‐Hao Chang, Yung‐Ming Jeng, Hsuan‐Cheng Huang and Hsin‐Yi Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Yung-Feng Liao

20 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yung-Feng Liao Taiwan 14 255 153 137 61 56 20 504
Alessandra Mangolini Italy 15 461 1.8× 130 0.8× 215 1.6× 26 0.4× 49 0.9× 20 715
Naoko Niimi Japan 17 367 1.4× 64 0.4× 119 0.9× 85 1.4× 36 0.6× 43 658
Huimin Dong China 12 262 1.0× 76 0.5× 100 0.7× 37 0.6× 31 0.6× 24 533
James Hamilton United States 14 499 2.0× 159 1.0× 129 0.9× 27 0.4× 28 0.5× 23 711
Hideji Yako Japan 16 301 1.2× 68 0.4× 67 0.5× 76 1.2× 35 0.6× 39 625
Evan E. Santo United States 9 545 2.1× 59 0.4× 88 0.6× 36 0.6× 51 0.9× 12 674
Yuanbin Xie Germany 12 426 1.7× 44 0.3× 91 0.7× 55 0.9× 34 0.6× 15 617
Illari Salvatori Italy 13 221 0.9× 138 0.9× 55 0.4× 26 0.4× 59 1.1× 20 420
Pedro Antas Portugal 12 571 2.2× 138 0.9× 99 0.7× 117 1.9× 99 1.8× 18 929
Emilie Schrepfer Italy 7 456 1.8× 45 0.3× 97 0.7× 54 0.9× 141 2.5× 7 633

Countries citing papers authored by Yung-Feng Liao

Since Specialization
Citations

This map shows the geographic impact of Yung-Feng Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yung-Feng Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yung-Feng Liao more than expected).

Fields of papers citing papers by Yung-Feng Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yung-Feng Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yung-Feng Liao. The network helps show where Yung-Feng Liao may publish in the future.

Co-authorship network of co-authors of Yung-Feng Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Yung-Feng Liao. A scholar is included among the top collaborators of Yung-Feng Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yung-Feng Liao. Yung-Feng Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Ching‐Pang, Thi Nguyen, Huimei Chen, et al.. (2021). Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy. Acta Neuropathologica Communications. 9(1). 112–112. 14 indexed citations
2.
Wang, Wen‐Der, Chi‐Hung Lin, Yung-Feng Liao, et al.. (2020). Piwi reduction in the aged niche eliminates germline stem cells via Toll-GSK3 signaling. Nature Communications. 11(1). 3147–3147. 20 indexed citations
3.
Wu, Pei‐Yi, Geen-Dong Chang, Kuan‐Hung Lin, et al.. (2019). Novel Endogenous Ligands of Aryl Hydrocarbon Receptor Mediate Neural Development and Differentiation of Neuroblastoma. ACS Chemical Neuroscience. 10(9). 4031–4042. 27 indexed citations
4.
5.
Her, Guor Mour, Yun‐Wen Chen, Pei‐Yi Wu, et al.. (2017). ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer’s disease. Proceedings of the National Academy of Sciences. 114(15). E3129–E3138. 66 indexed citations
6.
Weng, Wen‐Chin, Kuan‐Hung Lin, Pei‐Yi Wu, et al.. (2017). VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma. Scientific Reports. 7(1). 11212–11212. 7 indexed citations
7.
Lu, Meng‐Yao, Hsiu‐Hao Chang, Ching‐Chu Lu, et al.. (2016). Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma. Oncotarget. 7(14). 18774–18786. 22 indexed citations
8.
Yuan, Rey-Yue, et al.. (2016). Epicatechin isolated from Tripterygium wilfordii extract reduces tau-GFP-induced neurotoxicity in zebrafish embryo through the activation of Nrf2. Biochemical and Biophysical Research Communications. 477(2). 283–289. 12 indexed citations
9.
Yuan, Rey-Yue, Chin‐Chun Hung, Pung-Pung Hwang, et al.. (2016). Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo. Journal of Biomedical Science. 23(1). 25–25. 21 indexed citations
10.
Kuo, Yung‐Ting, Yen‐Lin Liu, Oluwaseun Adebayo Bamodu, et al.. (2015). JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells. PLoS ONE. 10(5). e0125343–e0125343. 54 indexed citations
11.
Weng, Wen‐Chin, Kuan‐Hung Lin, Pei‐Yi Wu, et al.. (2014). Calreticulin Regulates VEGF-A in Neuroblastoma Cells. Molecular Neurobiology. 52(1). 758–770. 14 indexed citations
12.
Lu, Yi-Chien, Chiung‐Nien Chen, Chia‐Ying Chu, et al.. (2014). Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cells. Biochemical Journal. 460(1). 69–80. 22 indexed citations
13.
Yang, Chung‐Hsiang, et al.. (2013). Zinc finger protein 219-like (ZNF219L) and Sox9a regulate synuclein-γ2 (sncgb) expression in the developing notochord of zebrafish. Biochemical and Biophysical Research Communications. 442(3-4). 189–194. 5 indexed citations
14.
Hsu, Wen‐Ming, et al.. (2013). Presenilin-1 Regulates the Expression of p62 to Govern p62-dependent Tau Degradation. Molecular Neurobiology. 49(1). 10–27. 12 indexed citations
15.
Lu, Meng‐Yao, Hsiu‐Hao Chang, Shiann‐Tarng Jou, et al.. (2012). Characterization of Neuroblastic Tumors Using 18F-FDOPA PET. Journal of Nuclear Medicine. 54(1). 42–49. 45 indexed citations
16.
Lin, Yun-Lian, et al.. (2012). The Components ofFlemingia macrophyllaAttenuate Amyloidβ-Protein Accumulation by Regulating Amyloidβ-Protein Metabolic Pathway. Evidence-based Complementary and Alternative Medicine. 2012. 1–9. 5 indexed citations
17.
Shih, Yu‐Yin, Hsinyu Lee, Akira Nakagawara, et al.. (2011). Nuclear GRP75 Binds Retinoic Acid Receptors to Promote Neuronal Differentiation of Neuroblastoma. PLoS ONE. 6(10). e26236–e26236. 24 indexed citations
18.
Huang, Tsui‐Chin, Hsin‐Yi Chang, Cheng‐Yu Chen, et al.. (2011). Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. FEBS Letters. 585(22). 3582–3586. 67 indexed citations
19.
Chang, Hsiu‐Hao, Hsinyu Lee, Po‐Nien Tsao, et al.. (2010). Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma. Clinical Cancer Research. 16(17). 4411–4420. 41 indexed citations
20.
Hsu, Wen‐Ming, Hsinyu Lee, Hsueh‐Fen Juan, et al.. (2008). Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis. Clinical Cancer Research. 14(19). 6237–6245. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Mangolini Breakdown of academic impact, for papers by Naoko Niimi Breakdown of academic impact, for papers by Huimin Dong Breakdown of academic impact, for papers by James Hamilton Breakdown of academic impact, for papers by Hideji Yako Breakdown of academic impact, for papers by Evan E. Santo Breakdown of academic impact, for papers by Yuanbin Xie Breakdown of academic impact, for papers by Illari Salvatori Breakdown of academic impact, for papers by Pedro Antas Breakdown of academic impact, for papers by Emilie Schrepfer
Rankless by CCL
2026